Purpose 68 Ga ligands targeting prostate-specific membrane antigen (PSMA) are rapidly
emerging as a significant step forward in the management of prostate cancer. PSMA is a …

Our purpose was to determine the relationship between serum prostate-specific antigen
(PSA) level categories (< 5, 5–10, 10–20, and> 20 ng/mL) and the incidence of bone …

Purpose To investigate the added value and diagnostic accuracy of 68 Ga-PSMA PET/CT
versus bone scintigraphy (BS) for bone metastasis detection at the primary staging of …

Please see the Editorial Comment by Sungmin Woo discussing this article. BACKGROUND.
Bone scintigraphy (BS) using 99mTc-labeled methylene diphospho-nate (99mTc-MDP) …

Background 68Ga‐labelled prostate‐specific membrane antigen (PSMA) is a promising PET
ligand for the detection of prostate cancer. Little attention has been given to the ability of …

Objection We aimed to evaluate the role of bone scintigraphy (BS) which has long been the
imaging modality of choice in prostate cancer (PCa) and performed a head-to-head …

Purpose The aim of our study was to compare the diagnostic performance of 68 Ga-PSMA
PET and 99m Tc bone scintigraphy (BS) for the detection of bone metastases in prostate …

Abstract Purpose of the Review Recently introduced Gallium-68 labeled PSMA-ligands such
as HBED-CC (68 Ga-PSMA) have shown promise for unmet diagnostic needs in prostate …

Imaging is critical for primary staging of prostate cancer. Traditional imaging modalities
(computerized tomography scan and nuclear medicine bone scans) are limited by their …

Abstract Purpose Prostate cancer (PCa) commonly metastasizes to the bones. There are
several radionuclide techniques for imaging PCa skeletal metastases. We aimed to compare …